Similar Articles
Changes in Serum Levels of Type-III Interferons in Ankylosing Spondylitis Treated With Tumor Necrosis Factor-Alpha Inhibitors
Da-min JIAO, Qiong-jie CHANG, Ping LI
DOI: 10.5606/ArchRheumatol.2019.6682
Analysis of Spinal Posture With Three-Dimensional Ultrasonic System in Patients With Ankylosing Spondylitis
Hakan Sercan KURTOĞLU, Filiz TUNA, Hakan TUNA, Enis ULUÇAM, Nurettin TAŞTEKİN, Murat BİRTANE
DOI: 10.5606/ArchRheumatol.2019.6795
Reliability and Validity of Turkish Version of Short Form of the Social Role Participation Questionnaire in Patients With Ankylosing Spondylitis
Yesim AKYOL, Yasemin ULUS, Yüksel TERZİ, Ayhan BİLGİCİ, Ömer KURU
DOI: 10.5606/ArchRheumatol.2018.6756
Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study
Nagehan ÖNCÜLOKUR, Dilek KESKİN, Yeşim GARİP, Hatice BODUR, Kenan KÖSE
DOI: 10.5606/ArchRheumatol.2018.6614
Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis
Ayla ÇAĞLIYAN TÜRK, Sertaç ARSLAN, Yusuf KARAVELİOĞLU, Macit KALCIK, Sumru ÖZEL, Ahmet MUSMUL, Füsun ŞAHİN
DOI: 10.5606/ArchRheumatol.2019.7145
Radiographic Progression in Patients With Ankylosing Spondylitis According to Uveitis Based on the Observation Study of Korean Spondyloarthropathy Registry
Hyunyi KOOK, So-hee JIN, Seunghun LEE, Seung-jin LEE, Tae-hwan KIM, Tae-Jong KIM
DOI: 10.5606/ArchRheumatol.2020.7095
Self-Reported Medication Adherence in Patients With Ankylosing Spondylitis: The Role of Illness Perception and Medication Beliefs
Sena TOLU, Aylin REZVANİ, İlhan KARACAN, Derya BUGDAYCI, Habib Can KÜÇÜK, Ömer Faruk BUCAK, Teoman AYDIN
DOI: 10.46497/ArchRheumatol.2020.7732
The Correlations Between Disease Specific Quality of Life, Short Form-36 and Clinical Variables in Patients With Ankylosing Spondylitis
Hakan ALKAN, Necmettin YILDIZ, Füsun ARDIÇ
DOI: 10.46497/ArchRheumatol.2020.7750
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
Ümit SARP, Evren ÜSTÜNER, Sehim KUTLAY, Şebnem ATAMAN, Sim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7868
Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks
Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK
DOI: 10.46497/ArchRheumatol.2021.7806
The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
Serdar KOKAR, Önder KAYHAN, Savaş ŞENCAN, Osman Hakan GÜNDÜZ
DOI: 10.46497/ArchRheumatol.2021.8043
Comparisons of +3179G/A insulin-like growth factor 1 receptor gene distribution between two inflammatory arthritides and healthy adults
Mariana IVANOVA, Irena MANOLOVA, Rumen STOILOV, Spaska STANILOVA
DOI: 10.46497/ArchRheumatol.2021.8234
Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea
In Ah Choi, Ji Hyoun Kim, Sung Hae Chang, Ran Song, You-Jung Ha, Hye Won Kim, Jeong Seok Lee, Byoongyong Choi, Yoon-Jeong Oh, Ki Won Moon
DOI: 10.46497/ArchRheumatol.2021.8524
Peer-led education or booklet for knowledge transfer about disease: A randomized-controlled trial with ankylosing spondylitis patients
Taciser Kaya, Pınar Atıcı, Altınay Göksel Karatepe, Rezzan Günaydın
DOI: 10.46497/ArchRheumatol.2021.8334
Relationship between diet, oxidative stress, and inflammation in ankylosing spondylitis
Kübra Tel Adıgüzel, Fatma Gül Yurdakul, Nilgün Seremet Kürklü, Evren Yaşar, Hatice Bodur
DOI: 10.46497/ArchRheumatol.2022.9015
Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
Ali Erhan Özdemirel, Serdar Can Güven, Zühre Sarı Sürmeli, Ayla Özyuvalı, Memet Kurt, Diana Rüstemova, Ayşe Peyman Yalçın Sayan, Hüseyin Tutkan, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2022.9819
Anti-tumor necrosis factor alpha treatment does not influence serum levels of the markers associated with radiographic progression in ankylosing spondylitis
Ali Erhan Özdemirel, Serdar Can Güven, Alper Doğancı, Zühre Sarı Sürmeli, Ayla Özyuvalı, Mehmet Kurt, Diana Rüstemova, Selin Hassan, Ayşe Peyman Yalçın Sayın, Hüseyin Tutkak, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2023.9974
Discovery of fecal microbial signatures in patients with ankylosing spondylitis
Yuquan You, Wei Zhang, Meimei Cai, Qingxin Guo, Jiawen Wang, Yaping Cai, Junsheng Lin
DOI: 10.46497/ArchRheumatol.2023.9124
Mevalonate kinase gene polymorphisms in ankylosing spondylitis patients: A cross-sectional study
Fatih Yıldız, Suzan Dinkçi, Eren Erken
DOI: 10.46497/ArchRheumatol.2023.9468
Aryl hydrocarbon receptor gene expression in ankylosing spondylitis and its correlation with interleukin-17, RAR-related orphan receptor gamma t expression, and disease activity indices
Maryam Ahmadi, Narjes Soleimanifar, Abdolrahman Rostamian, Maryam Sadr, Hanieh Mojtahedi, Abeda Mazari, Mohammad Hossein Nicknam, Sara Assadiasl
DOI: 10.46497/ArchRheumatol.2023.10203